Literature DB >> 21233845

MicroRNA miR-885-5p targets CDK2 and MCM5, activates p53 and inhibits proliferation and survival.

E A Afanasyeva1, P Mestdagh, C Kumps, J Vandesompele, V Ehemann, J Theissen, M Fischer, M Zapatka, B Brors, L Savelyeva, V Sagulenko, F Speleman, M Schwab, F Westermann.   

Abstract

Several microRNA (miRNA) loci are found within genomic regions frequently deleted in primary neuroblastoma, including miR-885-5p at 3p25.3. In this study, we demonstrate that miR-885-5p is downregulated on loss of 3p25.3 region in neuroblastoma. Experimentally enforced miR-885-5p expression in neuroblastoma cell lines inhibits proliferation triggering cell cycle arrest, senescence and/or apoptosis. miR-885-5p leads to the accumulation of p53 protein and activates the p53 pathway, resulting in upregulation of p53 targets. Enforced miR-885-5p expression consistently leads to downregulation of cyclin-dependent kinase (CDK2) and mini-chromosome maintenance protein (MCM5). Both genes are targeted by miR-885-5p via predicted binding sites within the 3'-untranslated regions (UTRs) of CDK2 and MCM5. Transcript profiling after miR-885-5p introduction in neuroblastoma cells reveals alterations in expression of multiple genes, including several p53 target genes and a number of factors involved in p53 pathway activity. Taken together, these data provide evidence that miR-885-5p has a tumor suppressive role in neuroblastoma interfering with cell cycle progression and cell survival.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21233845      PMCID: PMC3131937          DOI: 10.1038/cdd.2010.164

Source DB:  PubMed          Journal:  Cell Death Differ        ISSN: 1350-9047            Impact factor:   15.828


  34 in total

1.  Wild-type p53 can induce p21 and apoptosis in neuroblastoma cells but the DNA damage-induced G1 checkpoint function is attenuated.

Authors:  P P McKenzie; S M Guichard; D S Middlemas; R A Ashmun; M K Danks; L C Harris
Journal:  Clin Cancer Res       Date:  1999-12       Impact factor: 12.531

2.  Myc suppression of the p21(Cip1) Cdk inhibitor influences the outcome of the p53 response to DNA damage.

Authors:  Joan Seoane; Hong-Van Le; Joan Massagué
Journal:  Nature       Date:  2002-10-02       Impact factor: 49.962

3.  Frequent deletions and down-regulation of micro- RNA genes miR15 and miR16 at 13q14 in chronic lymphocytic leukemia.

Authors:  George Adrian Calin; Calin Dan Dumitru; Masayoshi Shimizu; Roberta Bichi; Simona Zupo; Evan Noch; Hansjuerg Aldler; Sashi Rattan; Michael Keating; Kanti Rai; Laura Rassenti; Thomas Kipps; Massimo Negrini; Florencia Bullrich; Carlo M Croce
Journal:  Proc Natl Acad Sci U S A       Date:  2002-11-14       Impact factor: 11.205

4.  Comparative genomic hybridization (CGH) analysis of stage 4 neuroblastoma reveals high frequency of 11q deletion in tumors lacking MYCN amplification.

Authors:  D Plantaz; J Vandesompele; N Van Roy; M Lastowska; N Bown; V Combaret; M C Favrot; O Delattre; J Michon; J Bénard; O Hartmann; J C Nicholson; F M Ross; C Brinkschmidt; G Laureys; H Caron; K K Matthay; B G Feuerstein; F Speleman
Journal:  Int J Cancer       Date:  2001-03-01       Impact factor: 7.396

5.  A rapid and simple method for measuring thymocyte apoptosis by propidium iodide staining and flow cytometry.

Authors:  I Nicoletti; G Migliorati; M C Pagliacci; F Grignani; C Riccardi
Journal:  J Immunol Methods       Date:  1991-06-03       Impact factor: 2.303

Review 6.  Genetic parameters of neuroblastomas.

Authors:  Frank Westermann; Manfred Schwab
Journal:  Cancer Lett       Date:  2002-10-28       Impact factor: 8.679

7.  Human microRNA genes are frequently located at fragile sites and genomic regions involved in cancers.

Authors:  George Adrian Calin; Cinzia Sevignani; Calin Dan Dumitru; Terry Hyslop; Evan Noch; Sai Yendamuri; Masayoshi Shimizu; Sashi Rattan; Florencia Bullrich; Massimo Negrini; Carlo M Croce
Journal:  Proc Natl Acad Sci U S A       Date:  2004-02-18       Impact factor: 11.205

8.  Annexin V for flow cytometric detection of phosphatidylserine expression on B cells undergoing apoptosis.

Authors:  G Koopman; C P Reutelingsperger; G A Kuijten; R M Keehnen; S T Pals; M H van Oers
Journal:  Blood       Date:  1994-09-01       Impact factor: 22.113

Review 9.  Neuroblastoma: biology and molecular and chromosomal pathology.

Authors:  Manfred Schwab; Frank Westermann; Barbara Hero; Frank Berthold
Journal:  Lancet Oncol       Date:  2003-08       Impact factor: 41.316

10.  Distinct transcriptional MYCN/c-MYC activities are associated with spontaneous regression or malignant progression in neuroblastomas.

Authors:  Frank Westermann; Daniel Muth; Axel Benner; Tobias Bauer; Kai-Oliver Henrich; André Oberthuer; Benedikt Brors; Tim Beissbarth; Jo Vandesompele; Filip Pattyn; Barbara Hero; Rainer König; Matthias Fischer; Manfred Schwab
Journal:  Genome Biol       Date:  2008-10-13       Impact factor: 13.583

View more
  60 in total

1.  Plasma miR-22-3p, miR-642b-3p and miR-885-5p as diagnostic biomarkers for pancreatic cancer.

Authors:  Neveen Abd El Moneim Hussein; Zenat A El Kholy; Medhat M Anwar; Mohamed A Ahmad; Shaymaa M Ahmad
Journal:  J Cancer Res Clin Oncol       Date:  2016-09-15       Impact factor: 4.553

Review 2.  microRNAs in cancer cell response to ionizing radiation.

Authors:  Jennifer R Czochor; Peter M Glazer
Journal:  Antioxid Redox Signal       Date:  2014-02-04       Impact factor: 8.401

3.  Acute Hepatitis C Virus Infection Induces Consistent Changes in Circulating MicroRNAs That Are Associated with Nonlytic Hepatocyte Release.

Authors:  Ramy El-Diwany; Lisa N Wasilewski; Kenneth W Witwer; Justin R Bailey; Kimberly Page; Stuart C Ray; Andrea L Cox; David L Thomas; Ashwin Balagopal
Journal:  J Virol       Date:  2015-07-08       Impact factor: 5.103

Review 4.  The role of genetic and epigenetic alterations in neuroblastoma disease pathogenesis.

Authors:  Raquel Domingo-Fernandez; Karen Watters; Olga Piskareva; Raymond L Stallings; Isabella Bray
Journal:  Pediatr Surg Int       Date:  2012-12-29       Impact factor: 1.827

Review 5.  MicroRNAs and DNA damage response: implications for cancer therapy.

Authors:  Yemin Wang; Toshi Taniguchi
Journal:  Cell Cycle       Date:  2012-12-19       Impact factor: 4.534

6.  Interaction of the oncogenic miR-21 microRNA and the p53 tumor suppressor pathway.

Authors:  Xiaodong Ma; Saibyasachi N Choudhury; Xiang Hua; Zhongping Dai; Yong Li
Journal:  Carcinogenesis       Date:  2013-02-05       Impact factor: 4.944

Review 7.  Role of oestrogen receptors in bladder cancer development.

Authors:  Iawen Hsu; Spencer Vitkus; Jun Da; Shuyuan Yeh
Journal:  Nat Rev Urol       Date:  2013-04-16       Impact factor: 14.432

Review 8.  The roles of microRNAs in neuroblastoma.

Authors:  Hong Mei; Zhen-Yu Lin; Qiang-Song Tong
Journal:  World J Pediatr       Date:  2014-01-25       Impact factor: 2.764

9.  Novel blood-based microRNA biomarker panel for early diagnosis of pancreatic cancer.

Authors:  Ganepola Ap Ganepola; John R Rutledge; Paritosh Suman; Anusak Yiengpruksawan; David H Chang
Journal:  World J Gastrointest Oncol       Date:  2014-01-15

Review 10.  Noncoding RNA control of cellular senescence.

Authors:  Kotb Abdelmohsen; Myriam Gorospe
Journal:  Wiley Interdiscip Rev RNA       Date:  2015-09-01       Impact factor: 9.957

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.